ARTL ARTL
Company Profile ↓Company Overview
ARTL (ARTL) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -97.48% |
| 6 Months: | -83.63% |
| 3 Months: | -75.61% |
| 1 Month: | -25.24% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)26.71 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 97.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Feb 2014 | May 2014 | Nov 2014 | Feb 2015 | May 2015 | Nov 2015 | Feb 2016 | May 2016 | Nov 2016 | Feb 2017 | May 2017 | Nov 2017 | Feb 2018 | May 2018 | Nov 2018 | Feb 2019 | May 2019 | Nov 2019 | Feb 2020 | May 2020 | Nov 2020 | Feb 2021 | Mar 2021 | May 2021 | Jun 2021 | Sep 2021 | Nov 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -6.59K | -8.15K | -2.00K | -6.15K | -2.50K | -15.22K | -5.09K | -5.05K | -9.52K | -11.99K | -95.72K | -277.06K | -798.46K | -577.86K | -556.90K | -757.92K | -941.29K | -1.34M | -1.37M | -951.39K | -1.44M | -1.87M | -1.70M | -2.25M | -2.25M | -2.25M | -2.55M | -1.95M | -2.47M | -2.39M | -2.29M | -1.78M | -2.61M | -2.59M | -2.51M | -1.20M | -2.38M | -3.15M | -3.09M | -2.69M |
| Net Income | -6.59K | -8.15K | -2.00K | -6.15K | -2.50K | -15.22K | -5.09K | -5.05K | -9.52K | -13.01K | -96.63K | -277.06K | -798.46K | -577.86K | -556.90K | -424.79K | -344.88K | -1.31M | -1.37M | -951.19K | -1.44M | -1.87M | -1.70M | -2.25M | -2.25M | -2.25M | -2.55M | -1.97M | -2.45M | -2.33M | -2.17M | -1.60M | -2.45M | -2.48M | -2.43M | -1.13M | -2.37M | -3.22M | -3.12M | -2.96M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 | -0.36 | -0.32 | -0.40 | -0.40 | -0.40 | -0.40 | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.83 | -0.78 | -4.52 | -2.10 | -12.55 | -5.61 | -3.97 | -4.00 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | 33.08K | 647.47K | 236.84K | 184.04K | 489.98K | 184.20K | 666.94K | 721.31K | 258.68K | 595.00K | 663.36K | 307.00K | 951.20K | 970.00K | 1.03M | 1.27M | 464.00K | 1.06M | 1.08M | 1.24M | 752.00K | 1.58M | 1.51M | 1.69M | 325.00K | 1.38M | 1.87M | 1.27M | 773.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -15.27K | -15.24K | -29.69K | -232.79K | -2.34M | -3.21M | -4.69M | -7.44M | -9.42M | -10.29M | -9.93M | -10.11M | -11.40M |
| Net Income | -15.27K | -15.24K | -29.69K | -234.89K | -2.34M | -2.17M | -4.66M | -7.44M | -9.41M | -10.08M | -9.29M | -9.83M | -12.88M |
| Diluted EPS | - | - | - | - | -1.84 | -1.46 | - | - | - | - | -3.14 | -18.30 | -12.52 |
| R&D Expense | - | - | - | - | 1.25M | 1.09M | 1.92M | 2.84M | 3.78M | 4.32M | 5.70M | 5.99M | 5.42M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 14.73K | 17.03K | 3.59K | 574.27K | 397.00K | 6.48M | 4.38M | 12.63M | 28.25M | 20.42M | 13.04M | 4.70M | 2.80M |
| Total Equity | 14.73K | 15.89K | -13.80K | 544.84K | -134.97K | 5.46M | 3.88M | 12.04M | 27.17M | 19.40M | 11.75M | 2.86M | -1.27M |
| Cash & Equivalents | 14.73K | 17.03K | 3.59K | 572.77K | 337.42K | 4.42M | 2.14M | 6.63M | 12.16M | 6.89M | - | - | 600.00K |
| Total Liabilities | - | 1.74K | 17.39K | - | - | - | 501.00K | 593.00K | 1.08M | 1.02M | 1.29M | 1.84M | 4.07M |
| Current Liabilities | - | 1.74K | 17.39K | 29.44K | 531.97K | 1.02M | 501.00K | 526.00K | 1.03M | 998.00K | 1.29M | 1.77M | 4.04M |
Cash Flows (Annual)
Figures in USD.
| Metric | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -216.82K | -1.61M | -2.79M | -4.35M | -6.14M | -8.01M | -8.21M | -8.35M | -8.52M |
| Investing Cash Flow | - | -845 | -1.50M | 0 | -3.44M | 2.96M | 3.51M | 7.77M | -62.00K |
| Financing Cash Flow | 785.35K | 1.39M | 8.38M | 1.98M | 14.11M | 0 | 567.00K | 112.00K | 6.87M |
Ratios (Annual)
Figures in %.
| Metric | Aug 2014 | Aug 2015 | Aug 2016 | Aug 2017 | Aug 2018 | Aug 2019 | Aug 2020 | Aug 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| ROE % | -103.7% | -95.9% | 215.1% | -43.1% | 1,736.3% | -39.8% | -120.1% | -61.8% | -34.6% | -52.0% | -79.0% | -343.9% | 1,012.5% |
| ROCE % | - | -99.7% | 215.1% | -42.7% | 1,736.3% | -58.8% | -120.9% | -61.5% | -34.6% | -53.0% | -84.5% | -345.5% | 917.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ARTL
Artelo Biosciences (ARTL) grants small stock option award to director - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPMzF6X0ppRWlGYV92VVlhNGFmR1dORWk3ZzhvdG56M2E0SkNVQ3k1QV9NZmRIYVdPeXpsYW1YQWFPNVo0S3NXM3hXSjk2WnVqN0J4ZnlaejZNbjVqX05iSk16QnplWlo5REI5ZG5lNFJrRlBVWlhhSkdMcWVTUkVPdHVvallSSDZJRzJ2R3…
Price to earnings forward of Artelo Biosciences, Inc. – NASDAQ:ARTL - TradingView
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNbFNxQ0ZWNktqNmRMMXdWc1o0TVBNSmw2OERBaUZnc1djdGx6UG9wS09pcHJyOW8zUFhtY2MyUTJVOHdyZlVSNWsyQk5YanZDNFdpa2hCZzltQURMYllFYlJZVmZ1TjFlYVh1S3R5TXZEZE1pTnVsWjdTLTJTYXhvZ2Rvakl0MHhQeGFWZT…
Why Is ARTL Stock Soaring Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNS1pWcGMtU3RpX21ZbTJEZTVMVlRhOHpnQlQ2czh3UlBhVFdaQTZRSnppUHdSVHh0M2lvZEd2dEg2LWlVNGpPaC1qbkRTaHBzU3h3enFLcC1qVUZGdEtQSDFvUlBOZG9wZ1F0SzlzcEx6R1h1ZXVUWEhwSkI4dWo2SWdPcWN2SWVPbGo0eG…
ARTL Stock In Focus As Artelo Biosciences Taps AI For Drug Pipeline - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOVTNiNFZSc1Z2ZGRsakhSeUVva1lzczJyajJWMEpIMlNvdTBsTGI0MVJ1WTRURWY1MENHakVQRU51Q08xcVFHSFdRR2tFLXVybGRPVmhObW10WC1qMU9xWWd5STh5VDdFeDcwM3hKN3JLclRCdGxUaHVGZjhhMF8zVg?oc=5" target="_…
Artelo Biosciences, Inc. Completes $11 Million Private Placement of Common Stock and Warrants - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxNb2lOSGpSeDVyeEU2RXJCcHZxenM1YS1kS2RFSTBGeGx4aU9OUzhtalp4VzVIR2xJWGhiUld3eHAwUk03WnlET2FyZnJnS25tNzBXY1liZ005TlhvQzI5eGd6VW8xbkItRjVnc2hOS3drakFuWkp0eC01YnFZeGVYd3dHU19fVmh3bGI2Vm…
Wondering what's happening in today's after-hours session? - ChartMill
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOS3VZQ0ZPbTR5UFM2YUR4VEdyLS10ZmhveWducGR5VzkxZzVoY2VLUUkwUHh2a1pWdTRZZkg0dTJjQ2U4bzhOSEZIOFQzNFlWRFM1ekIyeUdlUkZBSnZQVWo4WXdaMlV0cTFsRDRxNW16dEhaRjhXckR2RVQtSGJSMGprY2VTOUtRWTFRTU…
ARTL — Frequently Asked Questions
What is the current share price of ARTL?
As of 2026-08-05 17:25 PDT, ARTL trades at $0.75 on NASDAQ/NYSE. Its 52-week range is $0.72 to $30.39.
What is the P/E ratio of ARTL?
ARTL trades at a trailing price-to-earnings (P/E) ratio of -0.06.
Is ARTL a good stock to buy?
This page provides a data-driven analysis of ARTL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.